Functional genomics in identification of drug targets in Dupuytren's contracture

Frontiers in Bioscience

Volumn 15, Issue 1, 2010, Pages 57-64

  Sedic, Mirela ^a   Jurisic, Davor ^b   Stanec, Zdenko ^c   Hock, Karlo ^a   Pavelic, Kresimir ^a,d   Pavelic, Sandra Kraljevic ^a,d  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b KBC RIJEKA   (Croatia)

^c University of Zagreb   (Croatia)

^d University of Rijeka   (Croatia)

Author keywords

Bioinformatics; Dupuytren's contracture; Functional genomics; Proteomics; Review

Indexed keywords

ANIMALIA;

BIOLOGICAL MODEL; DRUG DELIVERY SYSTEM; DUPUYTREN CONTRACTURE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; HUMAN; LIPID METABOLISM; METABOLISM; METABOLOMICS; METHODOLOGY; PROTEOMICS; REVIEW;

DRUG DELIVERY SYSTEMS; DUPUYTREN CONTRACTURE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; LIPID METABOLISM; METABOLOMICS; MODELS, BIOLOGICAL; PROTEOMICS;

EID: 77951227700     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3606     Document Type: Article

References (45)

1. Tomasek J.J., G. Gabbiani, B. Hinz, C. Chaponnier, R.A. Brown: Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 3, 349-363 (2002). (Pubitemid 34619269)
2. Al-Qattan M.M.: Factors in the pathogenesis of Dupuytren's contracture. J Hand Surg Am 31A, 1527-1534 (2006). (Pubitemid 44692396)
3. Seyhan H., J. Kopp, S. Schultze-Mosgau, R.E. Horch: Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren's contracture. Plast Reconstr Surg 117, 1248-1252 (2006). (Pubitemid 44317818)
4. Hueston J.T.: Dupuytren's contracture. E&S Livingstone, Edinburgh, UK (1963).
5. Moyer K.E., D.R. Banducci, W.P. Graham, P.H. Ehrlich, D.E. Tredget: Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro. Plast Reconstr Surg 110, 187-196 (2002).
6. Gosset J.: Dupuytren's disease and the anatomy of the palmo-digital aponeurosis. Ann Chir 21, 554 (1967).
7. Luck J.V.: Dupuytren's contracture: A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 41, 635-664 (1959).
8. Gabbiani G., G. Majno: Dupuytren's contracture: fibroblast contraction? An ultrastructural study. Am J Pathol 66, 131-146 (1972).
9. Rayan G.M.: Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 89A, 190- 198 (2007).
10. Burge P., G. Hoy, P. Regan, R. Milne: Smoking, alcohol and the risk of Dupuytren's contracture. J Bone Joint Surg Br 79B, 206-210 (1997).
11. Godtfredsen N.S., H. Lucht, E. Prescott, T.I.A. Sorensen, M. Gronbaek: A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol 57, 858-863 (2004). (Pubitemid 39370171)
12. Mikkelsen O.A.: Dupuytren's disease - initial symptoms, age of onset and spontaneous course. Hand 9, 11-15 (1977). (Pubitemid 8035330)
13. Arkkila P.E., I.M. Kantola, J.S. Viikari: Dupuytren's disease: association with chronic diabetic complications. J Rheumatol 24, 153-159 (1997). (Pubitemid 27059874)
14. Arafa M., J. Noble, S.G. Royle, I.A. Trail, J. Allen: Dupuytren's and epilepsy revisited. J Hand Surg Br 17, 221-224 (1992).
15. A.V. Bonnici, F. Birjandi, J.D. Spencer, S.P. Fox, A.C. Berry: Chromosomal abnormalities in Dupuytren's contracture and carpal tunnel syndrome. J Hand Surg Br 17B, 349-355 (1992).
16. de la Caffiniere J.Y., R. Wagner, J. Etscheid, F. Metzger: Manual labor and Dupuytren disease. The results of a computerized survey in the field of iron metallurgy. Ann Chir Main 2, 66-72 (1983). (Pubitemid 13051533)
17. Badalamente M.A., L.C. Hurst, V.R. Hentz: Collagen as a clinical target: Nonoperative treatment of Dupuytren's disease. J Hand Surg Am 27A, 788-798 (2002).
18. Bayat A., J.S. Watson, J.K. Stanley, A. Alansari, M. Shah, M.W.J. Ferguson, W.E.R. Ollier: Genetic susceptibility in Dupuytren's disease - TGF-beta 1 polymorphisms and Dupuytren's disease. J Bone Joint Surg Br 84B, 211-215 (2002).
19. Bayat A., J.S. Watson, J.K. Stanley, M.W. Ferguson, W.E.R. Ollier: Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene. Plast Reconstr Surg 111, 2133-2139 (2003). (Pubitemid 36676785)
20. Berndt A., H. Kosmehl, D. Katenkamp, V. Tauchmann: Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix. Pathobiology 62, 55-58 (1994). (Pubitemid 24215140)
21. Brickley-Parsons D., M.J. Glimcher, R.J. Smith, R. Albin, J.P. Adams: Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am 63, 787-797 (1981). (Pubitemid 11127664)
22. Howard J.C., V.M. Varallo, D.C. Ross, K.J. Faber, J.H. Roth, S. Seney, B.S. Gan: Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren's contracture. J Surg Res 117, 232-238 (2004). (Pubitemid 38393648)
23. Neumüller J., J. Menzel, H. Millesi: Prevalence of HLA-DR3 and autoantibodies to connective tissue components in Dupuytren's contracture. Clin Immunol Immunopathol 71, 142-148 (1994). (Pubitemid 24147229)
24. Baird KS, J.F. Crossan, S.H. Ralston: Abnormal growth factor and cytokine expression in Dupuytren's contracture. J Clin Pathol 46, 425-428 (1993). (Pubitemid 23167416)
25. Qureshi F.I., R. Hornigold, J.D. Spencer, S.M. Hall: Langerhans cells in Dupuytren's contracture. J Hand Surg Br 26B, 362-367 (2001). (Pubitemid 32754963)
26. Gudmunson K.G., R. Arngrimsson, S. Arinbjarnarson, A. Olafson, T. Jonsson: T and B lymphocyte subsets in patients with Dupuytren's disease: Correlations with disease severity. J Hand Surg Br 23B, 724-727 (1998). (Pubitemid 29008407)
27. Fritzgerald A.M., J.J. Krikpatrick, I.T. Foo, I.L. Naylor: A picropolychrome staining technique applied to Dupuytren's tissue. J Hand Surg Br 20B, 519-524 (1995).
28. Jemec B., A.O. Grobbelaar, G.D. Wilson, P.J. Smith, R. Sanders, D.A. McGrouther: Is Dupuytren's disease caused by an imbalance between proliferation and cell death? J Hand Surg Br 24, 511-514 (1999). (Pubitemid 29520855)
29. Meek R.M., S. McLellan, J. Reilly, J.F. Crossan: The effect of steroids on Dupuytren's disease: role of programmed cell death. J Hand Surg Br 27, 270-273 (2002). (Pubitemid 34863354)
30. Murrell G.A., M.J. Francis, L. Bromley: Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265, 659-665 (1990). (Pubitemid 20053867)
31. Bayat A., J. Walter, H. Lambe, J.S. Watson, J.K. Stanley, M. Marino, M.W.J. Ferguson, W.E.R. Ollier: Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg 115, 134-141 (2005). (Pubitemid 40187807)
32. Kraljevic S., P.J. Stambrook, K. Pavelic: Accelerating drug discovery. EMBO Rep 5, 837-842 (2004).
33. Kraljevic S., M. Sedic, M. Scott, P. Gehrig, R. Schlapbach, K. Pavelic: Casting light on molecular events underlying anti-cancer drug treatment: What can be seen from the proteomics point of view? Cancer Treat Rev 32, 619-629 (2006). (Pubitemid 44752563)
34. Gershon D.: Microarrays go mainstream. Nat Meth 1, 263-270 (2004).
35. Pastwa E., S.B. Somiari, M. Czyz, R.I. Somiari: Proteomics in human cancer research. Prot Clin Appl 1, 4- 17 (2007).
36. Pan D., H.K. Watson, C. Swigart, J.G. Thomson, S.C. Honig, D. Narayan: Microarray gene analysis and expression profiles of Dupuytren's contracture. Ann Plast Surg 50, 618-622 (2003). (Pubitemid 36666699)
37. Qian A., R.A. Meals, J. Rajfer, N.F. Gonzalez-Cadavid: Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture. Urology 64, 399-404 (2004). (Pubitemid 39092491)
38. Rehman S., F. Salway, J.K. Stanley, W.E.R. Ollier, P. Day, A. Bayat: Molecular Phenotypic Descriptors of Dupuytren's Disease Defined Using Informatics Analysis of the Transcriptome. J Hand Surg Br 33, 359-372 (2008). (Pubitemid 351384747)
39. Fontana S., G. De Leo, M. Sedic, S. Kraljevic Pavelic, R. Alessandro: Proteomics in antitumor research. DDT: Tech 3, 441-449 (2006). (Pubitemid 46158387)
40. Bayat A., C. Winder, J. Stanley, P. Day, R. Goodacre: Proteome analysis of dupuytren's disease differentiating between disease tissue phenotypes (nodule, cord and transverse palmar fascia) and control palmar fascia. J Hand Surg Br 31, 5 (2006).
41. Kraljevic Pavelic S., M. Sedic, K. Hock, S. Vucinic, D. Jurisic, P. Gehrig, M. Scott, R. Schlapbach, T. Cacev, S. Kapitanovic, K. Pavelic: An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease. J Pathol 217, 524-533 (2009).
42. Sharan R., A. Ben Hur, G.G. Loots, I. Ovcharenko: CREME: Cis-Regulatory Module Explorer for the human genome. Nucleic Acids Res 32, W253-256 (2004). (Pubitemid 38997339)
43. Verrecchia F., J. Rossert, A. Mauviel: Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: Implications for the treatment of tissue fibrosis. J Invest Dermatol 116, 755-763 (2001). (Pubitemid 32467656)
44. Issaq H.J., T.P. Conrads, D.A. Prieto, R. Tirumalai, T.D. Veenstra: SELDI-TOF MS for diagnostic proteomics. Anal Chem 75, 148A-155A (2003). (Pubitemid 36512587)
45. O'Gorman D., J.C. Howard, V.M. Varallo, P. Cadieux, E. Bowley, K. McLean, B.J. Pak, B.S. Gan: Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS). Clin Invest Med 29, 136-145 (2006). (Pubitemid 43927072)